CorMedix Inc (CRMD)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 CONNELL DRIVE BERKELEY HEIGHTS, NJ 07922

Data as of 2020-09-12
Market Cap139.012 Million Shares Outstanding31.239 Million Avg 30-day Volume497.002 Thousand
P/E Ratio Dividend Yield EPS-1.88
Price/Sales795.239 Price cash flow ratio Price free cash flow ratio-8.5
Book Value0.59 Price to Tangible Book7.59 Alpha0.0
Short Interest Ratio7.31 % Short Interest to Float12.0 R-squared0.11517
BETA2.64659 52-week High/Low8.64 / 2.16 Stddev0.333216
View SEC Filings from CRMD instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 68 60 13.33% 14 (0.91%) 11 (0.7%) 27.27%
13F shares: 6.738 Million 6.614 Million 1.88% 1.845 Million 1.957 Million -5.69%
% Ownership 25.7903 25.3156 1.88% 7.0626 7.489 -5.69%
New Positions: 13 6 116.67% 5 3 66.67%
Increased Positions 23 21 9.52% 2 4 -50.0%
Closed Positions 4 8 -50.0% 2 3 -33.33%
Reduced Positions 12 12 0.0% 2 1 100.0%
Total Calls 68.31 Thousand 18.039 Thousand 278.68% 28.7 Thousand 13.2 Thousand 117.42%
Total Puts 173.389 Thousand 161.565 Thousand 7.32% 25.7 Thousand 14.9 Thousand 72.48%
PUT/CALL Ratio 2.54 8.96 -71.65% 0.9 1.13 -20.35%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CRMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

122.8 Thousand total shares from 16 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COSTA PAULO F

0 2020-09-15 2

LEFKOWITZ STEVEN W

92,650 2020-09-04 2

DAVID MATTHEW T CHIEF FINANCIAL OFFICER

1,150 2020-09-03 3

KAPLAN MYRON

150,034 2020-09-02 5

KHAN MEHMOOD

178,767 2020-08-18 3

DILLIONE JANET

53,473 2020-08-14 6

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

96,878 2020-08-14 3

BALUCH KHOSO CHIEF EXECUTIVE OFFICER

60,905 2020-08-13 3

MOUNTS PHOEBE GENERAL COUNSEL

7,200 2020-08-13 5

DUNTON ALAN W

6,250 2020-08-12 2

MASSON-HURLBURT ELIZABETH EVP, HEAD OF CLINICAL OPS.

8,000 2020-05-11 2

COOK ROBERT W. CHIEF FINANCIAL OFFICER

27,517 2019-09-30 1

GELBFISH GARY A.

2,668,871 2019-01-10 0

TELLEZ CORA M

  • Director
182,371 2017-05-30 0

GEORGE MICHAEL W

  • Director
10,000 2017-05-15 0

MARKVICKA TAUNIA

  • Director
37,100 2017-05-15 0

PFAFFLE ANTONY CHIEF SCIENTIFIC OFFICER

  • Officer
0 2017-02-07 0

ABRAMS JUDITH R CHIEF MEDICAL OFFICER

  • Officer
0 2017-02-01 0

MILBY RANDY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
403,269 2016-08-10 0

DUFFY MATTHEW

  • Director
28,571 2016-06-03 0

O'GRADY HARRY CHIEF FINANCIAL OFFICER

  • Officer
0 2014-07-21 0

COHEN RICHARD CHIEF FINANCIAL OFFICDER

  • Officer
  • Director
0 2013-03-20 0

PHARMABIO DEVELOPMENT INC

  • 10% Owner
778,563 2012-04-12 0

LENZ BRIAN SEE REMARKS

  • Officer
0 2012-03-20 0

HOFER TIMOTHY M

  • Director
0 2012-01-06 0

LEFKOWITZ JAMES

  • Director
40,272 2011-12-15 0

KLAUSNER MARK A. CHIEF MEDICAL OFFICER

  • Officer
0 2011-03-01 0

BASTANI BAMI

  • Director
0 2011-01-14 0

HOUSER MARK T. CHIEF MEDICAL OFFICER

  • Officer
52,832 2010-11-26 0

HOUGHTON JOHN C. PRESIDENT AND CEO

  • Officer
  • Director
17,328 2010-08-18 0

ELLISON RUSSELL H

  • Director
160,000 2010-03-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COSTA PAULO F

2020-09-17 08:38:15 -0400 2020-09-15 A 20,000 a 20,000 direct

COSTA PAULO F

2020-09-17 08:38:15 -0400 2020-09-15 A 3,750 a 3,750 direct

LEFKOWITZ STEVEN W

2020-09-09 08:47:39 -0400 2020-09-04 P 2,215 $3.98 a 60,498 direct -0.6623 1.1038 3.0905 4 -1.766 3

LEFKOWITZ STEVEN W

2020-09-09 08:47:39 -0400 2020-09-04 P 3,500 $4.00 a 58,283 direct -0.6623 1.1038 3.0905 4 -1.766 3

DAVID MATTHEW T CHIEF FINANCIAL OFFICER

2020-09-08 08:38:00 -0400 2020-09-03 P 1,150 $4.07 a 1,150 direct 2.9545 3.8636 6.1364 5 0.0 1

KAPLAN MYRON

2020-09-04 08:25:41 -0400 2020-09-02 P 15,300 $4.27 a 150,034 direct 10.0 16.75 16.75 6 0.0 1

KHAN MEHMOOD

2020-08-20 17:53:27 -0400 2020-08-19 P 9,404 $4.91 a 170,334 direct -5.9406 -4.3564 0.0 1 -6.9307 5

KHAN MEHMOOD

2020-08-20 17:53:27 -0400 2020-08-19 P 8,433 $4.90 a 178,767 direct -5.9406 -4.3564 0.0 1 -6.9307 5

KHAN MEHMOOD

2020-08-20 17:53:27 -0400 2020-08-18 P 2,331 $4.60 a 135,348 direct -5.9406 -4.3564 0.0 1 -6.9307 5

KHAN MEHMOOD

2020-08-20 17:53:27 -0400 2020-08-18 P 21,082 $4.86 a 160,930 direct -5.9406 -4.3564 0.0 1 -6.9307 5

KHAN MEHMOOD

2020-08-20 17:53:27 -0400 2020-08-18 P 4,500 $4.62 a 139,848 direct -5.9406 -4.3564 0.0 1 -6.9307 5

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

2020-08-17 20:06:52 -0400 2020-08-14 P 10,000 $4.16 a 79,378 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

2020-08-17 20:06:52 -0400 2020-08-14 P 10,000 $4.35 a 96,878 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

ARMSTRONG JR. JOHN L. EXEC VP OF TECH OPERATIONS

2020-08-17 20:06:52 -0400 2020-08-14 P 7,500 $4.14 a 86,878 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

DILLIONE JANET

2020-08-17 19:15:35 -0400 2020-08-14 A 4,770 a 4,770 direct

KAPLAN MYRON

2020-08-17 19:02:11 -0400 2020-08-13 P 15,000 $4.08 a 134,734 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

MOUNTS PHOEBE GENERAL COUNSEL

2020-08-17 19:08:24 -0400 2020-08-13 P 2,525 $4.03 a 7,200 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

BALUCH KHOSO CHIEF EXECUTIVE OFFICER

2020-08-17 18:45:57 -0400 2020-08-13 P 4,830 $4.14 a 60,905 direct 1.8595 -0.2066 4.3388 4 -5.7851 3

DUNTON ALAN W

2020-08-14 17:29:35 -0400 2020-08-12 P 5,000 $3.95 a 6,250 direct 9.7506 7.7098 14.5125 5 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments